Broad-spectrum non-nucleoside inhibitors of human herpesviruses

Antiviral Research

Volumn 121, Issue , 2015, Pages 16-23

  McClain, Lora ^a,b   Zhi, Yun ^a,c   Cheng, Hoyee ^a   Ghosh, Ayantika ^a   Piazza, Paolo ^d   Yee, Michael B ^e   Kumar, Santosh ^f   Milosevic, Jadranka ^e   Bloom, David C ^g   Arav Boger, Ravit ^f   Kinchington, Paul R ^d,e   Yolken, Robert ^f   Nimgaonkar, Vishwajit ^a,b   D'Aiuto, Leonardo ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c Tsinghua University   (China)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antiviral; Herpes simplex virus type 1; HSV; Human cytomegalovirus; Induced pluripotent stem cells; Varicella zoster virus

Indexed keywords

16D 20; 16F 19; 17G 7; 30N 12; 4F 17; ACICLOVIR; ANTIVIRUS AGENT; BAFILOMYCIN A1; CHLOROQUINE; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; GENE DOSAGE; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; IC50; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; VIRUS ENTRY; ANIMAL; CELL CULTURE; CELL SURVIVAL; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; HERPESVIRIDAE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; NERVE CELL; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 5; SIMPLEXVIRUS;

ANIMALS; ANTIVIRAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; HERPESVIRIDAE; HUMANS; MICROBIAL SENSITIVITY TESTS; NEURONS;

EID: 84933565947     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.06.005     Document Type: Article

References (30)

1. A. Bayer, E. Delorme-Axford, C. Sleigher, T.K. Frey, D.W. Trobaugh, W.B. Klimstra, L.A. Emert-Sedlak, T.E. Smithgall, P.R. Kinchington, S. Vadia, S. Seveau, J.P. Boyle, C.B. Coyne, and Y. Sadovsky Human trophoblasts confer resistance to viruses implicated in perinatal infection Am. J. Obstet. Gynecol. 212 2015 71.e71 71.e78
2. J.A. Blaho, C. Mitchell, and B. Roizman Guanylylation and adenylylation of the alpha regulatory proteins of herpes simplex virus require a viral beta or gamma function J. Virol. 67 1993 3891 3900
3. S. Burrel, C. Aime, L. Hermet, Z. Ait-Arkoub, H. Agut, and D. Boutolleau Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey Antiviral Res. 100 2013 365 372
4. M.J. Cannon, D.S. Schmid, and T.B. Hyde Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection Rev. Med. Virol. 20 2010 202 213
5. L. D'Aiuto, R. Di Maio, B. Heath, G. Raimondi, J. Milosevic, A.M. Watson, M. Bamne, W.T. Parks, L. Yang, B. Lin, T. Miki, J.D. Mich-Basso, R. Arav-Boger, E. Sibille, S. Sabunciyan, R. Yolken, and V. Nimgaonkar Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells PLoS One 7 2012 e49700
6. L. D'Aiuto, K.M. Prasad, C.H. Upton, L. Viggiano, J. Milosevic, G. Raimondi, L. McClain, K. Chowdari, J. Tischfield, M. Sheldon, J.C. Moore, R.H. Yolken, P.R. Kinchington, and V.L. Nimgaonkar Persistent infection by HSV-1 is associated with changes in functional architecture of iPSC-derived neurons and brain activation patterns underlying working memory performance Schizophr. Bull. 2014
7. K. Döhner, A. Wolfstein, U. Prank, C. Echeverri, D. Dujardin, R. Vallee, and B. Sodeik Function of dynein and dynactin in herpes simplex virus capsid transport Mol. Biol. Cell 13 2002 2795 2809
8. J.M. Harkness, M. Kader, and N.A. DeLuca Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells J. Virol. 88 2014 6847 6861
9. C.A. Harley, A. Dasgupta, and D.W. Wilson Characterization of herpes simplex virus-containing organelles by subcellular fractionation: role for organelle acidification in assembly of infectious particles J. Virol. 75 2001 1236 1251
10. R. He, G. Sandford, G.S. Hayward, W.H. Burns, G.H. Posner, M. Forman, and R. Arav-Boger Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors Virol. J. 8 2011 40
11. S. Iwayama, N. Ono, Y. Ohmura, K. Suzuki, M. Aoki, H. Nakazawa, M. Oikawa, T. Kato, M. Okunishi, Y. Nishiyama, and K. Yamanishi Antiherpesvirus activities of (1′S,2′R)-9-[[1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl]guanine (A-5021) in cell culture Antimicrob. Agents Chemother. 42 1998 1666 1670
12. H. Izzedine, V. Launay-Vacher, and G. Deray Antiviral drug-induced nephrotoxicity Am. J. Kidney Dis. 45 2005 804 817
13. D.C. Johnson, and J.D. Baines Herpesviruses remodel host membranes for virus egress Nat. Rev. Microbiol. 9 2011 382 394
14. P.E. Joubert, G. Meiffren, I.P. Grégoire, G. Pontini, C. Richetta, M. Flacher, O. Azocar, P.O. Vidalain, M. Vidal, V. Lotteau, P. Codogno, C. Rabourdin-Combe, and M. Faure Autophagy induction by the pathogen receptor CD46 Cell Host Microbe 6 2009 354 366
15. H.E. Kaufman, A.M. Azcuy, E.D. Varnell, G.D. Sloop, H.W. Thompson, and J.M. Hill HSV-1 DNA in tears and saliva of normal adults Invest. Ophthalmol. Vis. Sci. 46 2005 241 247
16. G. Kleymann, R. Fischer, U.A. Betz, M. Hendrix, W. Bender, U. Schneider, G. Handke, P. Eckenberg, G. Hewlett, V. Pevzner, J. Baumeister, O. Weber, K. Henninger, J. Keldenich, A. Jensen, J. Kolb, U. Bach, A. Popp, J. Mäben, I. Frappa, D. Haebich, O. Lockhoff, and H. Rübsamen-Waigmann New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease Nat. Med. 8 2002 392 398
17. M. Krepstakies, J. Lucifora, C.H. Nagel, M.B. Zeisel, B. Holstermann, H. Hohenberg, I. Kowalski, T. Gutsmann, T.F. Baumert, K. Brandenburg, J. Hauber, and U. Protzer A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses J. Infect. Dis. 205 2012 1654 1664
18. D. Malvy, M. Treilhaud, S. Bouée, A. Crochard, D. Vallée, A. El Hasnaoui, M. Aymard R.S. Group A retrospective, case-control study of acyclovir resistance in herpes simplex virus Clin. Infect. Dis. 41 2005 320 326
19. A.V. Nicola, J. Hou, E.O. Major, and S.E. Straus Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway J. Virol. 79 2005 7609 7616
20. T.J. Nieland, Y. Feng, J.X. Brown, T.D. Chuang, P.D. Buckett, J. Wang, X.S. Xie, T.E. McGraw, T. Kirchhausen, and M. Wessling-Resnick Chemical genetic screening identifies sulfonamides that raise organellar pH and interfere with membrane traffic Traffic 5 2004 478 492
21. P.J. Park, T.E. Antoine, A.V. Farooq, T. Valyi-Nagy, and D. Shukla An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection Invest. Ophthalmol. Vis. Sci. 54 2013 6373 6381
22. A.T. Pierce, J. DeSalvo, T.P. Foster, A. Kosinski, S.K. Weller, and W.P. Halford Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells J. Gen. Virol. 86 2005 2421 2432
23. S. Ramachandran, J.E. Knickelbein, C. Ferko, R.L. Hendricks, and P.R. Kinchington Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters Virology 378 2008 254 264
24. E. Schmutzhard Viral infections of the CNS with special emphasis on herpes simplex infections J. Neurol. 248 2001 469 477
25. I. Steiner, P.G. Kennedy, and A.R. Pachner The neurotropic herpes viruses: herpes simplex and varicella-zoster Lancet Neurol. 6 2007 1015 1028
26. R. Stránská, R. Schuurman, E. Nienhuis, I.W. Goedegebuure, M. Polman, J.F. Weel, P.M. Wertheim-Van Dillen, R.J. Berkhout, and A.M. van Loon Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization J. Clin. Virol. 32 2005 7 18
27. L. Strasfeld, and S. Chou Antiviral drug resistance. mechanisms and clinical implications Infect. Dis. Clin. North Am. 24 2010 809 833
28. S. Sukla, S. Biswas, A. Birkmann, P. Lischka, H. Zimmermann, and H.J. Field Mismatch primer-based PCR reveals that helicase-primase inhibitor resistance mutations pre-exist in herpes simplex virus type 1 clinical isolates and are not induced during incubation with the inhibitor J. Antimicrob. Chemother. 65 2010 1347 1352
29. F. Xu, M.R. Sternberg, B.J. Kottiri, G.M. McQuillan, F.K. Lee, A.J. Nahmias, S.M. Berman, and L.E. Markowitz Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States JAMA 296 2006 964 973
30. A. Zambrano, L. Solis, N. Salvadores, M. Cortés, R. Lerchundi, and C. Otth Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1 J. Alzheimers Dis. 14 2008 259 269